Propranolol Extended-Release Capsules
Form: Extended-Release Capsules
Strength: 60 mg, 80 mg, 120 mg, 160 mg
Reference Brands: Inderal LA®
Category: Antipsychotropic Drugs
Propranolol Extended-Release (ER) capsules are FDA-approved in the U.S. for treating hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. As a non-selective beta-blocker, it is subject to cardiovascular safety labeling, and extended-release formulations must meet modified-release and bioequivalence standards. U.S. regulations require GMP-compliant manufacturing, stability data, and ongoing pharmacovigilance. In the European Union, propranolol ER is authorized for similar indications under national approvals, with adherence to EMA guidance on beta-blockers. EU-specific requirements include Risk Management Plans (RMPs) and post-marketing surveillance. For dossier-ready Propranolol ER capsules, visit Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details
Zuclopenthixol Ong-Acting Im Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details
Zuclopenthixol Short-Acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details
Zuclopenthixol Tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details